Michael Winlo
Follow
Get notifications in MyBN when activity occurs.
Michael Winlo
Managing Director / Emyria
Most Notable Role
Dr Michael Winlo, chief executive of Emerald Clinics since August 2019, was chief executive of Linear Clinical Research for 3 years and remained on the board from July 2019 when he stepped down from the CEO role to lead a startup company in digital health innovation. Linear Clinical Research is the clinical trials arm of the Harry Perkins Institute of Medical Research.
He was a co-founder of medical device startup Cerulean Medical in 2007, and spent five years in the US growing the health practice of data analysis firm Palantir Technologies.
Dr Winlo holds a Bachelor of Medicine and Surgery from the University of Western Australia, and an MBA from the Stanford Graduate School of Business.
He was a co-founder of medical device startup Cerulean Medical in 2007, and spent five years in the US growing the health practice of data analysis firm Palantir Technologies.
Dr Winlo holds a Bachelor of Medicine and Surgery from the University of Western Australia, and an MBA from the Stanford Graduate School of Business.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1590th | Emyria | -56% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Emyria | $4.8m |
200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Non-Executive Director, Dorsavi | 25 Jul 2024 |
| NEW ROLE: Non-Executive Director, Nanoveu | 28 Mar 2023 |
| NEWS: Tagged in Healthtech banks on rising numbers | 07 Nov 2022 |
